We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
+$226M
Cap. Flow
+$18.1M
Cap. Flow %
0.98%
Top 10 Hldgs %
36.21%
Holding
2,856
New
200
Increased
717
Reduced
1,072
Closed
193
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
1.7 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.33%
2 Technology 13.72%
3 Financials 8.08%
4 Healthcare 7.07%
5 Consumer Discretionary 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BSM icon
2551
Black Stone Minerals
BSM
$3.14B
– –
-4,500
Closed -$28K –
BTAL icon
2552
AGF US Market Neutral Anti-Beta Fund
BTAL
$326M
$0 ﹤0.01%
23
– –
2020 Q1
3 quarters
BWAY icon
2553
Brainsway
BWAY
$476M
$0 ﹤0.01%
+20
New +$61
2020 Q4
0 quarters
CAL icon
2554
Caleres
CAL
$453M
– –
-174
Closed -$2K –
CBZ icon
2555
CBIZ
CBZ
$3.01B
$0 ﹤0.01%
8
– –
2020 Q2
2 quarters
CENTA icon
2556
Central Garden & Pet Co Class A
CENTA
$2.26B
– –
-743
Closed -$21K –
CHCO icon
2557
City Holding Co
CHCO
$1.98B
– –
-49
Closed -$3K –
CIM icon
2558
Chimera Investment
CIM
$716M
$0 ﹤0.01%
9
+1
+13% +$29
2016 Q4
16 quarters
CLNE icon
2559
Clean Energy Fuels
CLNE
$333M
$0 ﹤0.01%
+20
New +$78
2020 Q4
0 quarters
CLOV icon
2560
Clover Health Investments
CLOV
$2.49B
$0 ﹤0.01%
+10
New +$111
2020 Q4
0 quarters
CNMD icon
2561
CONMED
CNMD
$1.41B
– –
-89
Closed -$7K –
CPA icon
2562
Copa Holdings
CPA
$5.47B
$0 ﹤0.01%
3
– –
2020 Q2
2 quarters
CPRX icon
2563
DELISTED
Catalyst Pharmaceutical
CPRX
$0 ﹤0.01%
+2
New +$7
2020 Q4
0 quarters
CWI icon
2564
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.86B
– –
-6,545
Closed -$157K –
CXW icon
2565
CoreCivic
CXW
$3.09B
– –
-859
Closed -$7K –
DBVT icon
2566
DBV Technologies S.A. American Depositary Shares
DBVT
$573M
– –
-88
Closed -$2K –
DCTH icon
2567
Delcath Systems
DCTH
$514M
$0 ﹤0.01%
1
– –
2020 Q2
2 quarters
DENN icon
2568
DELISTED
Denny's
DENN
– –
-200
Closed -$2K –
DK icon
2569
Delek US
DK
$4.71B
– –
-93
Closed -$1K –
DNOW icon
2570
DNOW Inc
DNOW
$2.72B
– –
-231
Closed -$1K –
DON icon
2571
WisdomTree US MidCap Dividend Fund
DON
$3.87B
– –
-1,360
Closed -$39K –
EBND icon
2572
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.26B
$0 ﹤0.01%
15
– –
2020 Q2
2 quarters
ECVT icon
2573
Ecovyst
ECVT
$1.11B
– –
-94
Closed -$1K –
EGBN icon
2574
Eagle Bancorp
EGBN
$854M
$0 ﹤0.01%
6
– –
2020 Q2
2 quarters
EGO icon
2575
Eldorado Gold
EGO
$9.45B
– –
-9
Closed – –

Similar funds

Parallel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Parallel Advisors held 2,856 positions worth $1.84B, up 14% from $1.62B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q4 2020 filing shows 200 new, 717 increased, 1,072 reduced and 193 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M. The largest sale was Microsoft, an estimated $18.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M.
  • Parallel Advisors added most to iShares US Treasury Bond ETF in Q4 2020, an estimated $14.5M increase.
  • Parallel Advisors's biggest Q4 2020 reduction was Microsoft, cutting an estimated $18.3M.
  • Parallel Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $926K.
  • Parallel Advisors's ten largest holdings make up 36% of its $1.84B portfolio in Q4 2020.
  • Parallel Advisors opened 200 new positions and closed 193 in Q4 2020.
  • Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.84B.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.